PDCD1 and cancer: Drs. James Allison and Tasuku Honjo, discovered cytotoxic T‐lymphocyte‐associated protein 4 (CTLA‐4) and programmed cell death 1 (PD‐1) role as immune checkpoint inhibitors, which has transformed cancer therapy.10